Chemical Structure : ARD-2051
CAS No.: 2632305-17-8
货号: PC-21161Not For Human Use, Lab Use Only.
ARD-2051 (ARD-2051) is a potent and orally efficacious androgen receptor (AR) proteolysis-targeting chimera (PROTAC) degrader with DC50 of 0.6 nM in AR+ VCaP and LNCaP cell lines.
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
ARD-2051 (ARD-2051) is a potent and orally efficacious androgen receptor (AR) proteolysis-targeting chimera (PROTAC) degrader with DC50 of 0.6 nM in AR+ VCaP and LNCaP cell lines.
ARD-2051 shows Dmax >90% in inducing AR protein degradation in both the LNCaP and VCaP prostate cancer cell lines, potently and effectively suppresses AR-regulated genes, and inhibits cancer cell growth (VCaP and LNCaP, IC50=10 and 13 nM, respectively).
ARD-2051 (12.5 mg/kg) strongly reduces AR protein and suppresses AR-regulated gene expression in the VCaP xenograft tumor tissue in mice.
ARD-2051 (3.75, 7.5, 15, and 30 mg/kg) effectively inhibited tumor growth in the VCaP xenograft tumor model in SCID mice.
| 分子量 | 789.33 | |
| 分子式 | C43H45ClN8O5 | |
| 外观性状 | Solid | |
| 储存条件 |
|
|
| Solubility |
10 mM in DMSO |
|
| Chemical Name/SMILES |
2-Chloro-4-((3S)-8-(4-(4-(1-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)azetidin-3-yl)piperazine-1-carbonyl)phenyl)-3-methyl-2,8-diazaspiro[4.5]decan-2-yl)benzonitrile |
|
1. Xin Han, et al. J Med Chem. 2023 Jul 13;66(13):8822-8843.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright